Skip to main content
. 2005 Apr;166(4):1017–1028. doi: 10.1016/S0002-9440(10)62323-1

Figure 1.

Figure 1

Enhanced recovery from liver cirrhosis by HGF. a: Experimental schedule for development of liver cirrhosis by DMN administration and treatment with HGF. b: Histological analysis of hepatic sections. Hepatic sections were subjected to staining with H&E and immunohistochemical staining for α-SMA or desmin. c: Change in fibrotic area in rat livers untreated or treated with HGF. Fibrotic area was quantitated by computer-aided image analysis in hepatic tissue sections stained for α-SMA. Each value represents the mean ± SD (n = 8). d: Changes in the number of cells positive for α-SMA and desmin in the livers of rats untreated or treated with HGF. Each value represents the mean ± SD (n = 8). e: Changes in expression of hepatic α-SMA and desmin in livers of rats untreated or treated with HGF. Expression of α-SMA and desmin was analyzed using Western blots.